Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy
Authors:
Top Cited Papers
Open Access
- 17 January 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Mitochondrial damage constitutes the central pathological mechanism of cerebral ischemia-reperfusion (I/R) injury. Targeted delivery of antioxidants to mitochondria and the phenotype polarization of glial cells holds great promise for effective treatment. However, the blood-brain barrier (BBB) remains a major obstacle, causing insufficient drug accumulation in neuronal mitochondria. Here, we develop a bioengineered nanolamellar system (MM@BPPF) by coating microglia-mitochondria hybrid biomembrane onto black phosphorus nanosheets (BP NSs) loaded with polymetformin (PolyMet) and fingolimod hydrochloride (FTY720). Microglia membrane facilitates inflammation-directed targeting to the injured brain regions, while mitochondria membrane confers homotypic targeting to mitochondria. Meanwhile, BP NSs, PolyMet, and FTY720 act sequentially to restore mitochondrial function of neuronal cells and modulate microglial polarization. Intranasal administration enables MM@BPPF to bypass the BBB, substantially improving brain-targeting efficiency. This work not only offers an innovative sequential targeting strategy for mitigating I/R injury but also presents a potential paradigm for treating other central nervous system disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82573579)
- National Natural Science Foundation of China (32071387)
- National Natural Science Foundation of China (31872756)
- Alzheimer's Association (24AARFD-1192360)
- Alexander von Humboldt-Stiftung (/)
This publication has 86 references indexed in Scilit:
- Magnetic Field Driven Ceria Nanosystems for Mitochondria Targeted Therapy of Ischemic StrokeAdvanced Functional Materials, 2025
- Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α‐syn and Clearing ROS in Parkinson's DiseaseAdvanced Materials, 2024
- Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke TherapyAdvanced Materials, 2024
- Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's DiseaseAdvanced Materials, 2024
- Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke TherapyAdvanced Materials, 2024
- In Situ Mitochondrial Biomineralization for Drug‐Free Cancer TherapyAdvanced Materials, 2024
- Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer ImmunotherapyAdvanced Materials, 2023
- Drug‐Free Biomimetic Oxygen Supply Nanovehicle Promotes Ischemia‐Reperfusion Therapy in StrokeAdvanced Functional Materials, 2023
- Neuroprotective Treatments for Ischemic Stroke: Opportunities for NanotechnologyAdvanced Functional Materials, 2022
- Biomimetic Design of Mitochondria‐Targeted Hybrid Nanozymes as Superoxide ScavengersAdvanced Materials, 2021